Jiayong Liu1, Zhengfu Fan1, Marc El Beaino2,3, Valerae O Lewis3, Bryan S Moon3, Robert L Satcher3, Justin E Bird3, Spencer J Frink3, Patrick P Lin4. 1. Present address: Department of Bone and Soft Tissue Tumor, Peking University Cancer Hospital and Institute, Beijing, China. 2. Present address: Department of Orthopaedic Surgery and Rehabilitation Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, NY, USA. 3. Department of Orthopedic Oncology, MD Anderson Cancer Center, Houston, TX, USA. 4. Department of Orthopedic Oncology, MD Anderson Cancer Center, Houston, TX, USA. plin@mdanderson.org.
Abstract
BACKGROUND: Periprosthetic infection is a major cause of failure after segmental endoprosthetic reconstruction. The purpose of this study is to determine whether certain aspects of drain output affect infection risk, particularly the 30 mL/day criterion for removal. METHODS: Two hundred and ninety-five patients underwent segmental bone resection and lower limb endoprosthetic reconstruction at one institution. Data on surgical drain management and occurrence of infection were obtained from a retrospective review of patients' charts and radiographs. Univariate and multivariate Cox regression analyses were performed to identify factors associated with infection. RESULTS: Thirty-one of 295 patients (10.5%) developed infection at a median time of 13 months (range 1-108 months). Staphylococcus aureus was the most common organism and was responsible for the majority of cases developing within 1 year of surgery. Mean output at the time of drain removal was 72 mL/day. Ten of 88 patients (11.3%) with ≤ 30 mL/day drainage and 21 of 207 patients (10.1%) with > 30 mL/day drainage developed infection (p = 0.84). In multivariate analysis, independent predictive factors for infection included sarcoma diagnosis (HR 4.13, 95% CI 1.4-12.2, p = 0.01) and preoperative chemotherapy (HR 3.29, 95% CI 1.1-9.6, p = 0.03). CONCLUSION: Waiting until drain output is < 30 mL/day before drain removal is not associated with decreased risk of infection for segmental endoprostheses of the lower limb after tumor resection. Sarcoma diagnosis and preoperative chemotherapy were independent predictors of infection.
BACKGROUND: Periprosthetic infection is a major cause of failure after segmental endoprosthetic reconstruction. The purpose of this study is to determine whether certain aspects of drain output affect infection risk, particularly the 30 mL/day criterion for removal. METHODS: Two hundred and ninety-five patients underwent segmental bone resection and lower limb endoprosthetic reconstruction at one institution. Data on surgical drain management and occurrence of infection were obtained from a retrospective review of patients' charts and radiographs. Univariate and multivariate Cox regression analyses were performed to identify factors associated with infection. RESULTS: Thirty-one of 295 patients (10.5%) developed infection at a median time of 13 months (range 1-108 months). Staphylococcus aureus was the most common organism and was responsible for the majority of cases developing within 1 year of surgery. Mean output at the time of drain removal was 72 mL/day. Ten of 88 patients (11.3%) with ≤ 30 mL/day drainage and 21 of 207 patients (10.1%) with > 30 mL/day drainage developed infection (p = 0.84). In multivariate analysis, independent predictive factors for infection included sarcoma diagnosis (HR 4.13, 95% CI 1.4-12.2, p = 0.01) and preoperative chemotherapy (HR 3.29, 95% CI 1.1-9.6, p = 0.03). CONCLUSION: Waiting until drain output is < 30 mL/day before drain removal is not associated with decreased risk of infection for segmental endoprostheses of the lower limb after tumor resection. Sarcoma diagnosis and preoperative chemotherapy were independent predictors of infection.
Entities:
Keywords:
Bone resection; Periprosthetic infection; Sarcoma; Surgical drain
Authors: Carol D Morris; Kent Sepkowitz; Claudette Fonshell; Neil Margetson; Janet Eagan; Jeremy Miransky; Patrick J Boland; John Healey Journal: Ann Surg Oncol Date: 2003-08 Impact factor: 5.344
Authors: Fereidoon M Jaberi; Javad Parvizi; C Thomas Haytmanek; Ashish Joshi; James Purtill Journal: Clin Orthop Relat Res Date: 2008-04-11 Impact factor: 4.176
Authors: Khaled Saleh; Mary Olson; Scott Resig; Boris Bershadsky; Mike Kuskowski; Terence Gioe; Harry Robinson; Richard Schmidt; Edward McElfresh Journal: J Orthop Res Date: 2002-05 Impact factor: 3.494
Authors: James D Whitehouse; N Deborah Friedman; Kathryn B Kirkland; William J Richardson; Daniel J Sexton Journal: Infect Control Hosp Epidemiol Date: 2002-04 Impact factor: 3.254